Non-Current Assets
PP&E (Net)
AbbVie PP&E (Net) increased by 1.0% to $5.69B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.6%, from $5.24B to $5.69B. Over 5 years (FY 2020 to FY 2025), PP&E (Net) shows relatively stable performance with a 1.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 8, 2026
How to read this metric
High levels indicate significant investment in production capacity; a declining trend may suggest aging assets or a shift toward outsourcing.
Detailed definition
This represents the net book value of tangible assets like manufacturing facilities, laboratories, and equipment, after...
Peer comparison
Capital-intensive; peers in pharma maintain large footprints for manufacturing and R&D.
Metric ID:
property_plant_equipment_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.16B | $5.13B | $5.11B | $5.08B | $4.96B | $4.89B | $4.94B | $4.93B | $4.94B | $4.93B | $4.99B | $4.98B | $5.02B | $5.14B | $5.13B | $5.24B | $5.28B | $5.48B | $5.63B | $5.69B |
| QoQ Change | — | -0.6% | -0.4% | -0.7% | -2.3% | -1.3% | +0.9% | -0.1% | +0.2% | -0.2% | +1.1% | -0.2% | +0.9% | +2.3% | -0.1% | +2.0% | +0.9% | +3.8% | +2.6% | +1.0% |
| YoY Change | — | — | — | — | -3.9% | -4.6% | -3.4% | -2.8% | -0.3% | +0.8% | +1.1% | +1.0% | +1.6% | +4.2% | +2.9% | +5.2% | +5.2% | +6.7% | +9.6% | +8.6% |
Range$4.89B – $5.69B
CAGR+2.1%
Avg YoY Growth+2.0%
Median YoY Growth+1.4%
Current Streak5 quarters growth
Geographic Breakdown
| Segment | Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 |
|---|---|---|---|---|---|
| United States And Puerto Rico | $3.37B | $3.24B | $3.14B | $3.33B | $3.40B |
| Europe | $1.40B | $1.37B | $1.43B | $1.49B | $1.80B |
| All Other Countries | $341.00M | $323.00M | $417.00M | $318.00M | $420.00M |
| Total | $5.11B | $4.94B | $4.99B | $5.13B | $5.63B |
PP&E (Net) at Other Companies
Frequently Asked Questions
- What is AbbVie's pp&e (net)?
- AbbVie (ABBV) reported pp&e (net) of $5.69B in Q1 2026.
- How has AbbVie's pp&e (net) changed year-over-year?
- AbbVie's pp&e (net) increased by 8.6% year-over-year, from $5.24B to $5.69B.
- What is the long-term trend for AbbVie's pp&e (net)?
- Over 5 years (2020 to 2025), AbbVie's pp&e (net) has grown at a 1.4% compound annual growth rate (CAGR), from $5.25B to $5.63B.
- What does pp&e (net) mean?
- The value of the company's physical assets like buildings and machinery, minus wear and tear.